NO964216L - Ester- og karbamatderivater av azoloner som er kraftige midler mot Helicobacter - Google Patents
Ester- og karbamatderivater av azoloner som er kraftige midler mot HelicobacterInfo
- Publication number
- NO964216L NO964216L NO964216A NO964216A NO964216L NO 964216 L NO964216 L NO 964216L NO 964216 A NO964216 A NO 964216A NO 964216 A NO964216 A NO 964216A NO 964216 L NO964216 L NO 964216L
- Authority
- NO
- Norway
- Prior art keywords
- image
- pct
- 4alkyl
- 6alkyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Detergent Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94200938 | 1994-04-06 | ||
| PCT/EP1995/001184 WO1995027704A1 (en) | 1994-04-06 | 1995-03-29 | Anti-helicobacter ester and carbamate derivatives of azolones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO964216L true NO964216L (no) | 1996-10-04 |
| NO964216D0 NO964216D0 (no) | 1996-10-04 |
Family
ID=8216773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964216A NO964216D0 (no) | 1994-04-06 | 1996-10-04 | Ester- og karbamatderivater av azoloner som er kraftige midler mot Helicobacter |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5710156A (et) |
| EP (1) | EP0754180B1 (et) |
| JP (1) | JPH09511513A (et) |
| CN (1) | CN1145067A (et) |
| AT (1) | ATE207910T1 (et) |
| AU (1) | AU685935B2 (et) |
| BR (1) | BR9507289A (et) |
| CA (1) | CA2185552A1 (et) |
| CZ (1) | CZ287596A3 (et) |
| DE (1) | DE69523581T2 (et) |
| EE (1) | EE9600142A (et) |
| FI (1) | FI963995A (et) |
| HU (1) | HUT76287A (et) |
| IL (1) | IL113254A (et) |
| NO (1) | NO964216D0 (et) |
| NZ (1) | NZ283346A (et) |
| PL (1) | PL316655A1 (et) |
| SK (1) | SK127196A3 (et) |
| WO (1) | WO1995027704A1 (et) |
| ZA (1) | ZA952810B (et) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6780880B1 (en) * | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5250528A (en) * | 1989-08-02 | 1993-10-05 | Fujisawa Pharmaceutical Co., Ltd. | New aminopiperazine derivatives |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
| US5202346A (en) * | 1992-02-25 | 1993-04-13 | American Home Products Corporation | Piperidinyl and piperazinyl derivatives |
| TW279864B (et) * | 1993-02-19 | 1996-07-01 | Janssen Pharmaceutica Nv |
-
1995
- 1995-03-29 CA CA002185552A patent/CA2185552A1/en not_active Abandoned
- 1995-03-29 JP JP7526047A patent/JPH09511513A/ja not_active Ceased
- 1995-03-29 DE DE69523581T patent/DE69523581T2/de not_active Expired - Fee Related
- 1995-03-29 EE EE9600142A patent/EE9600142A/et unknown
- 1995-03-29 CN CN95192436A patent/CN1145067A/zh active Pending
- 1995-03-29 BR BR9507289A patent/BR9507289A/pt not_active Application Discontinuation
- 1995-03-29 NZ NZ283346A patent/NZ283346A/en unknown
- 1995-03-29 WO PCT/EP1995/001184 patent/WO1995027704A1/en active IP Right Grant
- 1995-03-29 US US08/716,397 patent/US5710156A/en not_active Expired - Fee Related
- 1995-03-29 AU AU21371/95A patent/AU685935B2/en not_active Ceased
- 1995-03-29 PL PL95316655A patent/PL316655A1/xx unknown
- 1995-03-29 CZ CZ962875A patent/CZ287596A3/cs unknown
- 1995-03-29 AT AT95914329T patent/ATE207910T1/de not_active IP Right Cessation
- 1995-03-29 SK SK1271-96A patent/SK127196A3/sk unknown
- 1995-03-29 EP EP95914329A patent/EP0754180B1/en not_active Expired - Lifetime
- 1995-03-29 HU HU9602725A patent/HUT76287A/hu unknown
- 1995-04-05 IL IL11325495A patent/IL113254A/xx not_active IP Right Cessation
- 1995-04-05 ZA ZA952810A patent/ZA952810B/xx unknown
-
1996
- 1996-10-04 NO NO964216A patent/NO964216D0/no unknown
- 1996-10-04 FI FI963995A patent/FI963995A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE9600142A (et) | 1997-04-15 |
| AU685935B2 (en) | 1998-01-29 |
| WO1995027704A1 (en) | 1995-10-19 |
| FI963995A0 (fi) | 1996-10-04 |
| DE69523581T2 (de) | 2002-07-11 |
| DE69523581D1 (de) | 2001-12-06 |
| MX9604610A (es) | 1997-11-29 |
| PL316655A1 (en) | 1997-02-03 |
| IL113254A0 (en) | 1995-07-31 |
| US5710156A (en) | 1998-01-20 |
| CN1145067A (zh) | 1997-03-12 |
| EP0754180A1 (en) | 1997-01-22 |
| NZ283346A (en) | 1997-05-26 |
| CZ287596A3 (en) | 1997-01-15 |
| SK127196A3 (en) | 1997-05-07 |
| HUT76287A (en) | 1997-07-28 |
| IL113254A (en) | 1999-03-12 |
| FI963995A (fi) | 1996-10-04 |
| JPH09511513A (ja) | 1997-11-18 |
| HU9602725D0 (en) | 1996-11-28 |
| BR9507289A (pt) | 1997-09-23 |
| NO964216D0 (no) | 1996-10-04 |
| CA2185552A1 (en) | 1995-10-19 |
| EP0754180B1 (en) | 2001-10-31 |
| AU2137195A (en) | 1995-10-30 |
| ZA952810B (en) | 1996-10-07 |
| ATE207910T1 (de) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700340A (es) | Agentes anti-helicobacter derivados sulfonamida de azolonas. | |
| MX9700339A (es) | Derivados de azolona anti-helcobacter que contienen urea y tiourea. | |
| NO964216L (no) | Ester- og karbamatderivater av azoloner som er kraftige midler mot Helicobacter | |
| DE69720715D1 (en) | Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel | |
| ES2173195T3 (es) | Derivados de antraciclina. | |
| ES2094567T3 (es) | Derivados de la 4-quinolinilo con actividad anti-helicobacter. | |
| DK0675895T3 (da) | Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling | |
| MY118312A (en) | Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives |